ストックスクリーナーアプリを入手
3.91
0.00%
0.00
アフターアワーズ：
3.99
0.08
+2.05%
前日終値:
$3.91
開ける：
$3.9898
24時間の取引高:
12,798
Relative Volume:
0.24
時価総額：
$42.03M
収益：
-
当期純損益:
$-34.36M
株価収益率:
-0.1094
EPS:
-35.74
ネットキャッシュフロー:
$-25.81M
1週間 パフォーマンス:
-11.34%
1か月 パフォーマンス:
-6.63%
6か月 パフォーマンス:
+8.61%
1年 パフォーマンス:
+23.30%
1日の値動き範囲:
$3.78
$4.06
1週間の範囲:
$3.77
$4.39
52週間の値動き範囲:
$1.75
$8.38
Calcimedica Inc Stock (CALC) Company Profile
Calcimedica Inc (CALC) 最新ニュース
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald
CalciMedica Inc [CALC] Shares Jump Approximately 60.20% Over the Year - Knox Daily
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Longview News-Journal
CalciMedica, Inc. (NASDAQ:CALC) Short Interest Down 6.5% in August - Defense World
Standard BioTools And 2 Other Penny Stocks Executives Are BuyingAult Alliance (AMEX:AULT) - Benzinga
CalciMedica CEO acquires $4,189 in stock at $4.20-$4.27 range - Investing.com
CalciMedica CEO acquires $4,189 in stock at $4.20-$4.27 range By Investing.com - Investing.com Canada
CalciMedica CEO acquires $4,189 in stock at $4.20-$4.27 range By Investing.com - Investing.com UK
CalciMedica expands equity incentive plan by 1.5 million shares - Investing.com
CalciMedica expands equity incentive plan by 1.5 million shares - Investing.com India
CalciMedica Shareholders Back Expansion and Elect Directors - TipRanks
CalciMedica, Inc. (NASDAQ:CALC) Insider Eric W. Roberts Purchases 5,000 Shares of Stock - Defense World
CalciMedica, Inc. (NASDAQ:CALC) Director Robert N. Wilson Acquires 54,000 Shares - Defense World
Director Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC) - Yahoo Finance UK
Director Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC) - Yahoo Finance
Director Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC) By GuruFocus - Investing.com Canada
Director Robert Wilson Acquires 54,000 Shares of CalciMedica Inc (CALC) - GuruFocus.com
Calcimedica director Wilson buys $200,826 in company stock - Investing.com India
Calcimedica director Wilson buys $200,826 in company stock By Investing.com - Investing.com Australia
Calcimedica director Wilson buys $200,826 in company stock - Investing.com
Calcimedica director Wilson buys $200,826 in company stock By Investing.com - Investing.com Canada
CalciMedica executive Eric W. Roberts buys $17.9k in company stock - Investing.com
Calcimedica director Wilson buys $200,826 in company stock By Investing.com - Investing.com UK
Eric W. Roberts Acquires 5,000 Shares of CalciMedica, Inc. (NASDAQ:CALC) Stock - Defense World
CalciMedica chief business officer buys $20,200 in stock By Investing.com - Investing.com Australia
CalciMedica chief business officer buys $20,200 in stock - Investing.com India
CalciMedica chief business officer buys $20,200 in stock By Investing.com - Investing.com UK
CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 - Longview News-Journal
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - Longview News-Journal
Oppenheimer maintains target on CalciMedica stock, sees growth potential By Investing.com - Investing.com Canada
Oppenheimer maintains target on CalciMedica stock, sees growth potential - Investing.com
Oppenheimer maintains target on CalciMedica stock, sees growth potential - Investing.com India
CalciMedica’s (CALC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
HC Wainwright Reiterates "Buy" Rating for CalciMedica (NASDAQ:CALC) - MarketBeat
CALC Stock Earnings: CalciMedica Beats EPS for Q2 2024 - MSN
CALC Stock Earnings: CalciMedica Beats EPS for Q2 2024 - InvestorPlace
CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PR Newswire
CalciMedica - The Pharma Letter
Understanding the Risks of Investing in CalciMedica Inc (CALC) - Knox Daily
Does CalciMedica Inc. (CALC) Have the Potential to Rally 232.3% as Wall Street Analysts Expect? - Yahoo Finance
Cognition Therapeutics (NASDAQ:CGTX) Stock Quotes, Forecast and News Summary - Benzinga
High-dose Auxora may improve time to solid food tolerance among pancratitis patients: Study - Medical Dialogues
CalciMedica, Inc. (NASDAQ:CALC) Short Interest Up 309.4% in June - Defense World
Daily Business Report: July 11, 2024 - San Diego Metropolitan
CalciMedica (NASDAQ:CALC) Price Target Raised to $20.00 at Oppenheimer - Defense World
CalciMedica shares target raised by Oppenheimer on promising AKI trial - Investing.com
CalciMedica shares target raised by Oppenheimer on promising AKI trial - Investing.com UK
CalciMedica begins patient dosing in Phase II trial of Auxora for AKI - Clinical Trials Arena
CalciMedica begins patient dosing in Phase II trial of Auxora for AKI - Yahoo Finance
CalciMedica (NASDAQ:CALC) Receives Buy Rating from HC Wainwright - Defense World
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI) - PR Newswire
Calcimedica Inc (CALC) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
1.31%
大文字化:
|
ボリューム (24 時間):